Arizona Blood and Cancer Specialists, PLLC

Arizona Blood and Cancer Specialists, PLLC was paid $894K by Medicaid between Jun 2019 and Dec 2024, across 16 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 51% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	1,329	$43K
2020	3,686	$150K
2021	5,577	$196K
2022	5,191	$218K
2023	4,028	$158K
2024incomplete	3,095	$129K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	51%	11,842	10,031	$460K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	13%	3,237	2,927	$118K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	10%	1,443	1,305	$93K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	7.2%	1,715	1,190	$64K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	5.7%	831	498	$51K
J0897	Injection, denosumab, 1 mg	3.8%	46	38	$34K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	1.7%	248	244	$15K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.6%	2,042	1,556	$14K
77014		1.4%	183	40	$12K
78815	Positron emission tomography (PET) for limited area imaging	1.3%	14	13	$12K
96367		<1%	612	366	$9K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	29	26	$5K

4 more codes

Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	<1%	21	$3K
J1756	Injection, iron sucrose, 1 mg	<1%	92	$3K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	539	$560.88
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	12	$105.74

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialALEXANDER, JENNIFER (CREDENTIALING SPECIALIST)